Henry Schein, Inc.  

(Public, NASDAQ:HSIC)   Watch this stock  
Find more results for HSIC
67.97
-0.71 (-1.03%)
After Hours: 67.97 0.00 (0.00%)
Feb 22, 4:10PM EST  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 67.83 - 69.78
52 week 63.01 - 93.50
Open 69.25
Vol / Avg. 1.89M/2.31M
Mkt cap 10.67B
P/E 19.55
Div/yield     -
EPS 3.48
Shares 153.69M
Beta 1.00
Inst. own 101%
May 7, 2018
Q1 2018 Henry Schein Inc Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Mar 14, 2018
Henry Schein Inc at Barclays Global Healthcare Conference - 9:30AM EDT - Add to calendar
Feb 20, 2018
Q4 2017 Henry Schein Inc Earnings Call - Webcast
Feb 20, 2018
Q4 2017 Henry Schein Inc Earnings Release
Jan 9, 2018
Henry Schein Inc at JPMorgan Healthcare Conference - Webcast
Dec 5, 2017
Henry Schein Inc at Nasdaq Investor Program - Webcast
Nov 28, 2017
Henry Schein Inc at Piper Jaffray Healthcare Conference - Webcast
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '17) 2017
Net profit margin 4.97% 4.84%
Operating margin 7.27% 6.90%
EBITD margin - 8.45%
Return on average assets 8.64% 8.28%
Return on average equity 18.52% 19.60%
Employees 21,000 -
CDP Score - -

Address

135 Duryea Rd
MELVILLE, NY 11747
United States - Map
+1-631-8435500 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Henry Schein, Inc. is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins. The technology and value-added services segment provides software, technology and other value-added services to healthcare practitioners. Its technology group offerings include practice management software systems for dental and medical practitioners and animal health clinics. The Company provides its services to dental practitioners and laboratories, animal health clinics and physician practices, as well as government and institutional healthcare clinics.

Officers and directors

Stanley M. Bergman Chairman of the Board, Chief Executive Officer
Age: 67
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
James P. Breslawski CPA President, Director; Chief Executive Officer of Henry Schein Global Dental Group
Age: 63
Bio & Compensation  - Reuters
Steven Paladino CPA Chief Financial Officer, Executive Vice President, Director
Age: 60
Bio & Compensation  - Reuters
Peter McCarthy President of Global Animal Health Group
Age: 57
Bio & Compensation  - Reuters
David C. McKinley President of Corporate Commercial Development Group, Chief Commercial Officer
Age: 64
Bio & Compensation  - Reuters
Bob Minowitz President, International Dental Group, EMEA Region
Age: 58
Bio & Compensation  - Reuters
Bridget A. Ross President of Global Medical Group
Age: 52
Bio & Compensation  - Reuters
Gerald A. Benjamin Chief Administrative Officer, Executive Vice President, Director
Age: 64
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Mark E. Mlotek Chief Strategic Officer, Executive Vice President, Director
Age: 61
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Karen N. Prange Executive Vice President; Chief Executive Officer of Global Animal Health, Medical and Dental Surgical Group
Age: 53
Bio & Compensation  - Reuters